Title: Full Text of HB1272
Official Title: 
Number of Sections: 1
Source: versions - House Amendment 001
Media Type: text/html

================================================================================

Section 1:
Full Text of HB1272 ILGA.GOV HB1272 - 104th General Assembly Rep. Maurice A. West, IIFiled: 2/20/2025   10400HB1272ham001LRB104 06227 BAB 22733 a1AMENDMENT TO HOUSE BILL 1272 2    AMENDMENT NO. ______. Amend House Bill 1272 by replacing 3everything after the enacting clause with the following: 4    "Section 1. Short title. This Act may be cited as the 5Wholesale Prescription Drug Importation Program Act. 6    Section 5. Definitions. As used in this Act: 7    "Canadian supplier" means a manufacturer, wholesale 8distributor, or pharmacy that is appropriately licensed or 9permitted under Canadian federal or provincial laws and rules 10to manufacture, distribute, or dispense prescription drugs. 11    "Department" means the Department of Public Health. 12    "Director" means the Director of Public Health.13    "Prescription drug wholesaler" means a person or entity 14licensed as a wholesale drug distributor under the Wholesale 15Drug Distribution Licensing Act, that contracts with this 16State to import prescription drugs under the program.   10400HB1272ham001- 2 -LRB104 06227 BAB 22733 a1    "Program" means the Wholesale Prescription Drug 2Importation Program. 3    Section 10. Wholesale Prescription Drug Importation 4Program. 5    (a) The Department shall establish the Wholesale 6Prescription Drug Importation Program to provide lower cost 7prescription drugs available outside of the United States to 8consumers in this State at the lower cost.9    (b) The Department shall implement the program by:10        (1) contracting with one or more prescription drug 11    wholesalers and Canadian suppliers to import prescription 12    drugs and provide prescription drug cost savings to 13    consumers in this State;14        (2) developing a registration process for health 15    benefit plan issuers, health care providers, and 16    pharmacies to obtain and dispense prescription drugs 17    imported under the program;18        (3) developing a list of prescription drugs, including 19    the prices of those drugs, that meet the requirements of 20    Section 15 and publishing the list on the Department's 21    website; 22        (4) establishing an outreach and marketing plan to 23    generate program awareness;24        (5) establishing and administering a telephone call 25    center or electronic portal to provide information about   10400HB1272ham001- 3 -LRB104 06227 BAB 22733 a1    the program;2        (6) ensuring the program and the prescription drug 3    wholesalers that contract with this State under paragraph 4    (1) comply with the tracking, tracing, verification, and 5    identification requirements of 21 U.S.C. 360eee-1;6        (7) prohibiting the distribution, dispensing, or sale 7    of prescription drugs imported under this Act outside the 8    boundaries of this State; and 9        (8) performing any other duties the Director 10    determines necessary to implement the program. 11    (c) The Department shall ensure that the program meets the 12requirements of 21 U.S.C. 384.13    (d) In developing the program, the Department may consult 14with interested parties.  15    Section 15. Eligible prescription drugs. A prescription 16drug may be imported into this State under the program only if 17the drug:18        (1) meets the United States Food and Drug 19    Administration's standards related to prescription drug 20    safety, effectiveness, misbranding, and adulteration;21        (2) does not violate any federal patent laws through 22    its importation; 23        (3) is expected to generate cost savings for 24    consumers; and25        (4) is not:  10400HB1272ham001- 4 -LRB104 06227 BAB 22733 a1            (A) listed as a controlled substance under State 2        or federal law;3            (B) a biological product;4            (C) an infused drug;5            (D) an intravenously injected drug;6            (E) a drug that is inhaled during surgery; or7            (F) a parenteral drug.  8    Section 20. Program expansion. In its discretion, the 9Department may by rule expand the Program to import 10prescription drugs from any other country that is allowed 11under federal law to import prescription drugs into the United 12States. 13    Section 25. Program funding. In addition to money 14appropriated by the General Assembly, the Department may 15impose a fee on each prescription drug sold under the program 16or establish another funding method to administer the program.  17    Section 30. Audit procedures. The Director, by rule, shall 18develop procedures to effectively audit a prescription drug 19wholesaler participating in the program.  20    Section 35. Annual reporting. Not later than December 1, 212026, and each December 1 thereafter, the Department shall 22submit a report to the Governor and the General Assembly   10400HB1272ham001- 5 -LRB104 06227 BAB 22733 a1regarding the operation of the program during the preceding 2State fiscal year, including: 3        (1) which prescription drugs and Canadian suppliers 4    are included in the program;5        (2) the number of health benefit plan issuers, health 6    care providers, and pharmacies participating in the 7    program; 8        (3) the number of prescriptions dispensed through the 9    program; 10        (4) the estimated cost savings to consumers, health 11    plans, employers, and this State since the establishment 12    of the program and during the preceding State fiscal year; 13        (5) information regarding the implementation of the 14    audit procedures under Section 30; and 15        (6) any other information: 16            (A) the Governor or the General Assembly requests; 17        or18            (B) the Department considers necessary.  19    Section 40. Rules. As soon as practicable after the 20effective date of this Act, the Director shall adopt any rules 21necessary to implement this Act.  22    Section 45. Federal waiver or authorization. If, before 23implementing any provision of this Act, a State agency 24determines that a waiver or authorization from a federal   10400HB1272ham001- 6 -LRB104 06227 BAB 22733 a1agency is necessary for implementation of that provision, the 2agency affected by the provision shall request the waiver or 3authorization and may delay implementing that provision until 4the waiver or authorization is granted.  5    Section 99. Effective date. This Act takes effect July 1, 62025.".


================================================================================

Raw Text:
Full Text of HB1272 ILGA.GOV HB1272 - 104th General Assembly Rep. Maurice A. West, IIFiled: 2/20/2025   10400HB1272ham001LRB104 06227 BAB 22733 a1AMENDMENT TO HOUSE BILL 1272 2    AMENDMENT NO. ______. Amend House Bill 1272 by replacing 3everything after the enacting clause with the following: 4    "Section 1. Short title. This Act may be cited as the 5Wholesale Prescription Drug Importation Program Act. 6    Section 5. Definitions. As used in this Act: 7    "Canadian supplier" means a manufacturer, wholesale 8distributor, or pharmacy that is appropriately licensed or 9permitted under Canadian federal or provincial laws and rules 10to manufacture, distribute, or dispense prescription drugs. 11    "Department" means the Department of Public Health. 12    "Director" means the Director of Public Health.13    "Prescription drug wholesaler" means a person or entity 14licensed as a wholesale drug distributor under the Wholesale 15Drug Distribution Licensing Act, that contracts with this 16State to import prescription drugs under the program.   10400HB1272ham001- 2 -LRB104 06227 BAB 22733 a1    "Program" means the Wholesale Prescription Drug 2Importation Program. 3    Section 10. Wholesale Prescription Drug Importation 4Program. 5    (a) The Department shall establish the Wholesale 6Prescription Drug Importation Program to provide lower cost 7prescription drugs available outside of the United States to 8consumers in this State at the lower cost.9    (b) The Department shall implement the program by:10        (1) contracting with one or more prescription drug 11    wholesalers and Canadian suppliers to import prescription 12    drugs and provide prescription drug cost savings to 13    consumers in this State;14        (2) developing a registration process for health 15    benefit plan issuers, health care providers, and 16    pharmacies to obtain and dispense prescription drugs 17    imported under the program;18        (3) developing a list of prescription drugs, including 19    the prices of those drugs, that meet the requirements of 20    Section 15 and publishing the list on the Department's 21    website; 22        (4) establishing an outreach and marketing plan to 23    generate program awareness;24        (5) establishing and administering a telephone call 25    center or electronic portal to provide information about   10400HB1272ham001- 3 -LRB104 06227 BAB 22733 a1    the program;2        (6) ensuring the program and the prescription drug 3    wholesalers that contract with this State under paragraph 4    (1) comply with the tracking, tracing, verification, and 5    identification requirements of 21 U.S.C. 360eee-1;6        (7) prohibiting the distribution, dispensing, or sale 7    of prescription drugs imported under this Act outside the 8    boundaries of this State; and 9        (8) performing any other duties the Director 10    determines necessary to implement the program. 11    (c) The Department shall ensure that the program meets the 12requirements of 21 U.S.C. 384.13    (d) In developing the program, the Department may consult 14with interested parties.  15    Section 15. Eligible prescription drugs. A prescription 16drug may be imported into this State under the program only if 17the drug:18        (1) meets the United States Food and Drug 19    Administration's standards related to prescription drug 20    safety, effectiveness, misbranding, and adulteration;21        (2) does not violate any federal patent laws through 22    its importation; 23        (3) is expected to generate cost savings for 24    consumers; and25        (4) is not:  10400HB1272ham001- 4 -LRB104 06227 BAB 22733 a1            (A) listed as a controlled substance under State 2        or federal law;3            (B) a biological product;4            (C) an infused drug;5            (D) an intravenously injected drug;6            (E) a drug that is inhaled during surgery; or7            (F) a parenteral drug.  8    Section 20. Program expansion. In its discretion, the 9Department may by rule expand the Program to import 10prescription drugs from any other country that is allowed 11under federal law to import prescription drugs into the United 12States. 13    Section 25. Program funding. In addition to money 14appropriated by the General Assembly, the Department may 15impose a fee on each prescription drug sold under the program 16or establish another funding method to administer the program.  17    Section 30. Audit procedures. The Director, by rule, shall 18develop procedures to effectively audit a prescription drug 19wholesaler participating in the program.  20    Section 35. Annual reporting. Not later than December 1, 212026, and each December 1 thereafter, the Department shall 22submit a report to the Governor and the General Assembly   10400HB1272ham001- 5 -LRB104 06227 BAB 22733 a1regarding the operation of the program during the preceding 2State fiscal year, including: 3        (1) which prescription drugs and Canadian suppliers 4    are included in the program;5        (2) the number of health benefit plan issuers, health 6    care providers, and pharmacies participating in the 7    program; 8        (3) the number of prescriptions dispensed through the 9    program; 10        (4) the estimated cost savings to consumers, health 11    plans, employers, and this State since the establishment 12    of the program and during the preceding State fiscal year; 13        (5) information regarding the implementation of the 14    audit procedures under Section 30; and 15        (6) any other information: 16            (A) the Governor or the General Assembly requests; 17        or18            (B) the Department considers necessary.  19    Section 40. Rules. As soon as practicable after the 20effective date of this Act, the Director shall adopt any rules 21necessary to implement this Act.  22    Section 45. Federal waiver or authorization. If, before 23implementing any provision of this Act, a State agency 24determines that a waiver or authorization from a federal   10400HB1272ham001- 6 -LRB104 06227 BAB 22733 a1agency is necessary for implementation of that provision, the 2agency affected by the provision shall request the waiver or 3authorization and may delay implementing that provision until 4the waiver or authorization is granted.  5    Section 99. Effective date. This Act takes effect July 1, 62025.".